Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Santander – page 40

611 clinical trials in Santander, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Santander at a glance
611
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

611 trials in Santander

Open in trial search

Study on Durvalumab with Trimodality Therapy for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Fundacion Cris De Investigacion Para Vencer El Cancer

Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Syndax Pharmaceuticals Inc.

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study of Durvalumab with Chemoradiation Therapy for Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Plasma cell myeloma

Not recruiting

Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Plasma cell myeloma

Not recruiting

Study on the Long-Term Safety of Isatuximab for Adults with Multiple Myeloma Benefiting from Isatuximab Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Human ALPHA-1-PROTEINASE inhibitor immunoglobulin G fusion protein, recombinant
  • Sponsor:Sanofi AATD Inc.

Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Essa Pharma Inc.

Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Santander

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on metastatic colorectal cancer, mantle cell lymphoma, and gastrointestinal cancers. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.

  • Colorectal Cancer Treatment Innovations
  • Lymphoma Therapy Advances
  • Gastric Cancer Interventions

Multiple studies exploring new therapeutic approaches for various cancer types, including melanoma and lung cancer.

02 Respiratory Medicine

Clinical trials investigating treatments for chronic rhinosinusitis and uncontrolled asthma. Research focuses on developing innovative therapies and improving patient quality of life.

  • Asthma Management
  • Nasal Polyps Treatment
  • Respiratory Disease Control

Studies evaluate both established and novel therapeutic approaches for respiratory conditions.

03 Autoimmune Disorders

Innovative research examining treatments for psoriatic arthritis and Sjögren's disease. Trials focus on evaluating new biological therapies and their effectiveness in managing symptoms.

  • Arthritis Treatment Solutions
  • Autoimmune Disease Management
  • Biological Therapy Assessment

Comprehensive studies targeting various manifestations of autoimmune conditions.

04 Neurological Studies

Research investigating treatments for Alzheimer's disease and its connection with Down syndrome. Studies also include trials for multiple sclerosis and related neurological conditions.

  • Alzheimer's Disease Research
  • Multiple Sclerosis Treatments
  • Neurological Disease Management

Focused on developing effective treatments for complex neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.